❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭ Kjersti Flatmark's group ❭ Major collaborators ❭

Major collaborators

Academic collaborations

PERIMMUNE

The Section of Cellular Therapy

Pathology Research Radiumhospitalet 

EuroPMP

 

Commercial collaborations

Nadeno

Node

Bayer

 

 

 

 

 
Scroll to top

Home Dept. of Tumor Biology Kjersti Flatmark's group

  • Group members
  • From bench to bedside
  • Interventional clinical trials
  • Target discovery in peritoneal surface malignancies
  • Locally advanced and recurrent rectal cancer
  • Experimental treatment
  • Publications
  • News
  • Major collaborators

Recent publications

Davidson B, Stričak LM, Holth A, Torgunrud A, Wohlschlaeger J, Tötsch M, Bassarova A (2026)
The specificity of HEG1 as mesothelioma marker depends on the differential diagnosis
Virchows Arch (in press)
DOI 10.1007/s00428-026-04438-w, PubMed 41656400

Thorgersen EB, Dagenborg VJ, Schultz JK (2026)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies: How, to whom, and is centralization needed?
Scand J Surg, 14574969261418796 (in press)
DOI 10.1177/14574969261418796, PubMed 41655138

Landsverk HB, Sandquist LE, Bay LTE, Hauge S, van Bijsterveldt L, Lindbergsengen L, Lund-Andersen C, Kanduri C, Lyng H, Fjeldbo CS, Hompland T, Humphrey TC, Syljuåsen RG (2026)
Transcription termination counteracts DNA damage after WEE1 inhibition
Nucleic Acids Res, 54 (3)
DOI 10.1093/nar/gkaf1487, PubMed 41569153



More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)